Skip to main content
Passa alla visualizzazione normale.

MANFREDI RIZZO

GLP-1 and dual GIP/GLP-1 receptor agonists in overweight/obese patients for atherosclerotic cardiovascular disease prevention: Where are we now?

Abstract

none